Letter to the Editor
Comments on the Treatment of Resistant Tuberculosis
Comentarios al tratamiento de la tuberculosis con resistencia
José Francisco Pascual Pareja
Servicio de Medicina Interna, Unidad de Tuberculosis, Complejo Hospitalario La Paz-Cantoblanco-Carlos III, Madrid, Spain
Read
3819
Timeswas read the article
1626
Total PDF
2193
Total HTML
Share statistics
array:24 [ "pii" => "S1579212918300831" "issn" => "15792129" "doi" => "10.1016/j.arbr.2017.10.023" "estado" => "S300" "fechaPublicacion" => "2018-05-01" "aid" => "1763" "copyright" => "SEPAR" "copyrightAnyo" => "2017" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2018;54:297" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 998 "formatos" => array:3 [ "EPUB" => 131 "HTML" => 578 "PDF" => 289 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S030028961730409X" "issn" => "03002896" "doi" => "10.1016/j.arbres.2017.10.017" "estado" => "S300" "fechaPublicacion" => "2018-05-01" "aid" => "1763" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2018;54:297" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1355 "formatos" => array:3 [ "EPUB" => 130 "HTML" => 782 "PDF" => 443 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Comentarios al tratamiento de la tuberculosis con resistencia" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "297" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Comments On The Treatment Of Resistant Tuberculosis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José Francisco Pascual Pareja" "autores" => array:1 [ 0 => array:2 [ "nombre" => "José Francisco" "apellidos" => "Pascual Pareja" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212918300831" "doi" => "10.1016/j.arbr.2017.10.023" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918300831?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S030028961730409X?idApp=UINPBA00003Z" "url" => "/03002896/0000005400000005/v1_201805020858/S030028961730409X/v1_201805020858/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1579212918300892" "issn" => "15792129" "doi" => "10.1016/j.arbr.2018.03.001" "estado" => "S300" "fechaPublicacion" => "2018-05-01" "aid" => "1805" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2018;54:298" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1077 "formatos" => array:3 [ "EPUB" => 154 "HTML" => 599 "PDF" => 324 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Comments on the SEPAR Guidelines for the Diagnosis and Treatment of Drug-Resistant Tuberculosis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "298" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Comentarios a la normativa SEPAR de diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José A. Caminero, Joan A. Caylá, José-María García-García, Francisco J. García-Pérez, Juan J. Palacios, Juan Ruiz-Manzano" "autores" => array:6 [ 0 => array:2 [ "nombre" => "José A." "apellidos" => "Caminero" ] 1 => array:2 [ "nombre" => "Joan A." "apellidos" => "Caylá" ] 2 => array:2 [ "nombre" => "José-María" "apellidos" => "García-García" ] 3 => array:2 [ "nombre" => "Francisco J." "apellidos" => "García-Pérez" ] 4 => array:2 [ "nombre" => "Juan J." "apellidos" => "Palacios" ] 5 => array:2 [ "nombre" => "Juan" "apellidos" => "Ruiz-Manzano" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289618300139" "doi" => "10.1016/j.arbres.2017.12.015" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289618300139?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918300892?idApp=UINPBA00003Z" "url" => "/15792129/0000005400000005/v1_201804290447/S1579212918300892/v1_201804290447/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1579212918300880" "issn" => "15792129" "doi" => "10.1016/j.arbr.2017.09.019" "estado" => "S300" "fechaPublicacion" => "2018-05-01" "aid" => "1756" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Bronconeumol. 2018;54:295-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1163 "formatos" => array:3 [ "EPUB" => 127 "HTML" => 725 "PDF" => 311 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Pulmonary Lesions: Cause or Consequence of Respiratory Infection?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "295" "paginaFinal" => "296" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Lesión pulmonar: ¿causa o consecuencia de infección respiratoria?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1162 "Ancho" => 2500 "Tamanyo" => 237083 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) PA chest X-ray: unilocular air cyst in left lung base. (B) Chest CT: thin-walled air cavity in left lower lobe. (C) PA chest X-ray: increased density in right upper lobe of the lung. No cystic lesion is observed. (D) PA chest X-ray: unilocular air cyst in right lung. (E) PA chest X-ray: increased density in right lung. (F) Chest CT: image of thin-walled unilocular cyst containing air, located in the apical segment of the right lower lobe.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Javier Nogueira López, Laura Díaz Munilla, Natividad Viguria Sánchez, Laura Moreno-Galarraga" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Javier" "apellidos" => "Nogueira López" ] 1 => array:2 [ "nombre" => "Laura" "apellidos" => "Díaz Munilla" ] 2 => array:2 [ "nombre" => "Natividad" "apellidos" => "Viguria Sánchez" ] 3 => array:2 [ "nombre" => "Laura" "apellidos" => "Moreno-Galarraga" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289617304027" "doi" => "10.1016/j.arbres.2017.09.017" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617304027?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918300880?idApp=UINPBA00003Z" "url" => "/15792129/0000005400000005/v1_201804290447/S1579212918300880/v1_201804290447/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Comments on the Treatment of Resistant Tuberculosis" "tieneTextoCompleto" => true "saludo" => "To the Editor," "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "297" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "José Francisco Pascual Pareja" "autores" => array:1 [ 0 => array:3 [ "nombre" => "José Francisco" "apellidos" => "Pascual Pareja" "email" => array:1 [ 0 => "josefrancisco.pascual@salud.madrid.org" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Medicina Interna, Unidad de Tuberculosis, Complejo Hospitalario La Paz-Cantoblanco-Carlos III, Madrid, Spain" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Comentarios al tratamiento de la tuberculosis con resistencia" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">I read with interest the guidelines published by Caminero et al.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a> on the diagnosis and treatment of drug-resistant tuberculosis. I agree that according to the published evidence, bedaquiline and delamanid should be considered essential components in the design of multidrug-resistant (MDR) tuberculosis treatment regimens, as the authors set out in their rational classification and sequential use of anti-TB drugs for the design of a treatment regimen (Caminero et al., Table 3<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a>). Indeed, the 2016 WHO classification<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> should have included them in group C (other core second-line drugs) along with linezolid, rather than in group D (add-on agents, not part of the core regimen). Caminero et al., however, seem to give a greater theoretical than practical value to bedaquiline and delamanid, as treatment regimens with these drugs are not recommended from the outset, probably for the same reason that WHO included them in group D2: these drugs are very costly. Nevertheless, it is important to bear in mind that some studies have shown that the inclusion of these expensive drugs in multi-resistant tuberculosis treatment is a cost-effective measure.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">3,4</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">These guidelines recommend that priority be given to the shorter 9–12 month regimen proposed by the WHO in 2016, known as the “9-month Bangladesh regimen”,<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> for all patients with rifampicin or multiresistant tuberculosis who have not previously received fluoroquinolones (FQ) or second-line injectable drugs (SLID) or who can demonstrate sensitivity in vitro to these 2 classes of antibiotics. The WHO also recommends that this regimen should not be used in patients with suspected or confirmed resistance to 1 or more drugs in a shorter regimen (e.g., pyrazinamide), apart from FQs and SLIDs. Some studies have raised serious questions about the suitability of shorter regimens in certain regions of the world (including some European countries), due to the prevalent resistance patterns in those areas.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> Moreover, the shorter regimen should be avoided in patients with extrapulmonary disease and in pregnancy.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a></p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Pascual Pareja JF. Comentarios al tratamiento de la tuberculosis con resistencia. Arch Bronconeumol. 2018;54:297.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis and treatment of drug-resistant tuberculosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.A. Caminero" 1 => "J.A. Cayla" 2 => "J.M. García-García" 3 => "F.J. García-Pérez" 4 => "J.J. Palacios" 5 => "J. Ruiz-Manzano" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arbres.2017.02.006" "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2017" "volumen" => "53" "paginaInicial" => "501" "paginaFinal" => "509" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28359606" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "WHO treatment guidelines for drug-resistant tuberculosis. 2016 update. Available from: <a id="intr0010" class="elsevierStyleInterRef" href="http://apps.who.int/iris/bitstream/10665/250125/1/9789241549639-eng.pdf?ua=1">http://apps.who.int/iris/bitstream/10665/250125/1/9789241549639-eng.pdf?ua=1</a> [reviewed October 2016], [accessed 30.09.17]." ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D. Wirth" 1 => "R. Dass" 2 => "R. Hettle" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s12913-017-2118-2" "Revista" => array:5 [ "tituloSerie" => "BMC Health Serv Res" "fecha" => "2017" "volumen" => "17" "paginaInicial" => "182" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28270207" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cost-effectiveness of adding bedaquiline to drug regimens for the treatment of multidrug-resistant tuberculosis in the UK" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L.J. Wolfson" 1 => "A. Walker" 2 => "R. Hettle" 3 => "X. Lu" 4 => "C. Kambili" 5 => "A. Murungi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0120763" "Revista" => array:5 [ "tituloSerie" => "PLOS ONE" "fecha" => "2015" "volumen" => "10" "paginaInicial" => "e0120763" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25794045" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Limited benefit of the new shorter multidrug-resistant tuberculosis regimen in Europe" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Lange" 1 => "R. Duarte" 2 => "M. Fréchet-Jachym" 3 => "G. Guenther" 4 => "L. Guglielmetti" 5 => "I.D. Olaru" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.201606-1097LE" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2016" "volumen" => "194" "paginaInicial" => "1029" "paginaFinal" => "1031" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27685538" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15792129/0000005400000005/v1_201804290447/S1579212918300831/v1_201804290447/en/main.assets" "Apartado" => array:4 [ "identificador" => "45358" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15792129/0000005400000005/v1_201804290447/S1579212918300831/v1_201804290447/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918300831?idApp=UINPBA00003Z" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 6 | 2 | 8 |
| 2024 October | 44 | 14 | 58 |
| 2024 September | 54 | 13 | 67 |
| 2024 August | 74 | 34 | 108 |
| 2024 July | 43 | 21 | 64 |
| 2024 June | 54 | 29 | 83 |
| 2024 May | 63 | 35 | 98 |
| 2024 April | 46 | 24 | 70 |
| 2024 March | 27 | 25 | 52 |
| 2024 February | 41 | 21 | 62 |
| 2023 March | 5 | 4 | 9 |
| 2023 February | 29 | 18 | 47 |
| 2023 January | 26 | 31 | 57 |
| 2022 December | 39 | 40 | 79 |
| 2022 November | 48 | 22 | 70 |
| 2022 October | 46 | 39 | 85 |
| 2022 September | 43 | 35 | 78 |
| 2022 August | 32 | 43 | 75 |
| 2022 July | 29 | 46 | 75 |
| 2022 June | 29 | 38 | 67 |
| 2022 May | 45 | 31 | 76 |
| 2022 April | 35 | 31 | 66 |
| 2022 March | 37 | 37 | 74 |
| 2022 February | 46 | 22 | 68 |
| 2022 January | 35 | 43 | 78 |
| 2021 December | 35 | 44 | 79 |
| 2021 November | 29 | 37 | 66 |
| 2021 October | 30 | 44 | 74 |
| 2021 September | 32 | 45 | 77 |
| 2021 August | 15 | 34 | 49 |
| 2021 July | 22 | 29 | 51 |
| 2021 June | 35 | 41 | 76 |
| 2021 May | 38 | 47 | 85 |
| 2021 April | 84 | 115 | 199 |
| 2021 March | 36 | 29 | 65 |
| 2021 February | 21 | 18 | 39 |
| 2021 January | 31 | 15 | 46 |
| 2020 December | 21 | 14 | 35 |
| 2020 November | 22 | 18 | 40 |
| 2020 October | 27 | 21 | 48 |
| 2020 September | 17 | 13 | 30 |
| 2020 August | 20 | 14 | 34 |
| 2020 July | 29 | 30 | 59 |
| 2020 June | 26 | 2 | 28 |
| 2020 May | 45 | 13 | 58 |
| 2020 March | 13 | 7 | 20 |
| 2020 February | 33 | 17 | 50 |
| 2020 January | 46 | 14 | 60 |
| 2019 December | 23 | 8 | 31 |
| 2019 November | 31 | 19 | 50 |
| 2019 October | 37 | 18 | 55 |
| 2019 September | 33 | 5 | 38 |
| 2019 August | 30 | 22 | 52 |
| 2019 July | 16 | 23 | 39 |
| 2019 June | 37 | 7 | 44 |
| 2019 May | 41 | 21 | 62 |
| 2019 April | 38 | 28 | 66 |
| 2019 March | 42 | 29 | 71 |
| 2019 February | 29 | 20 | 49 |
| 2019 January | 37 | 18 | 55 |
| 2018 December | 42 | 21 | 63 |
| 2018 November | 65 | 27 | 92 |
| 2018 October | 9 | 1 | 10 |
Show all
